IHH seeks RM5.5bil from Japan’s Daiichi for Fortis deal


PETALING JAYA: IHH Healthcare Bhd says its unit is seeking compensation of up to 109.3 billion rupees (RM5.46bil) from Japan’s Daiichi Sankyo for its stake buy in India’s Fortis Healthcare.

In October 2023, Northern TK Venture (NTK), a subsidiary of IHH Healthcare, had filed a claim against the Japanese pharmaceuticals manufacturer saying it caused losses to the company by preventing it from proceeding with open offers to buy a stake in Fortis Healthcare in 2018.

The company had initially claimed 20 billion yen (RM581.9mil) that Daiichi was ordered to pay as damages to NTK in November 2023.

After a report by an expert, NTK now claims compensation of between 4.24 billion rupees and 109.3 billion rupees.

IHH Healthcare, Asia’s largest healthcare group, had halted its open offer to buy an additional 26% stake in Fortis after Daiichi filed a contempt plea against Fortis founders, according to media reports.

Both Daiichi and Fortis did not immediately respond to a Reuters request for comment. — Reuters

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

MN Holdings wins RM122.7mil contracts for data centre power works
M&G enters JV to expand vessel maintenance and repair services
Binastra wins RM1.18bil building, infrastructure contracts in Johor
FBM KLCI retreats on profit-taking despite stronger GDP data
Indonesia’s B50 delay opens short-term export window for Malaysian palm oil
Taiwan aims to be strategic AI partner in US tariff deal
Oil prices inch up as market evaluates supply risks
CPO to trade around RM4,000 a tonne in 2026, according to Kenanga
Gold slips as upbeat US data boosts dollar, dims rate-cut bets
Rakuten Trade raises FBM KLCI year-end target, sees stronger earnings and fund flows

Others Also Read